Last quarter (Q2 2022), Bioera SpA's total revenue was €―, a decrease of ― from the same quarter last year. In Q2, Bioera SpA's net income was €―. See Bioera SpA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 20	Dec 19	Dec 18	Dec 17	Dec 16
Total Revenue	-	€ 10.33M	€ 26.44M	€ 41.34M	€ 47.09M	€ 52.92M
Cost of Revenue	-	€ 11.88M	€ 25.89M	€ 37.26M	€ 43.06M	€ 48.33M
Gross Profit	-	€ -1.55M	€ 547.00K	€ 4.08M	€ 4.04M	€ 4.59M
Operating Expense	-	€ 4.43M	€ 5.21M	€ 5.88M	€ 7.83M	€ 6.03M
Operating Income	-	€ -5.98M	€ -4.66M	€ -1.81M	€ -3.79M	€ -1.44M
Net Non Operating Interest Income Expense	-	€ -794.00K	€ -437.00K	€ -416.00K	€ -396.00K	€ -186.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	€ -7.13M	€ -6.99M	€ -3.40M	€ -5.93M	€ -1.74M
Tax Provision	-	€ 214.00K	€ 390.00K	€ 684.00K	€ 831.00K	€ 997.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	€ -2.95M	€ -5.97M	€ -3.63M	€ -5.15M	€ -2.79M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	€ 377.00K	€ 131.00K	€ 904.00K	€ 1.48M	€ 1.66M
Total Expenses	-	€ 16.31M	€ 31.10M	€ 43.15M	€ 50.88M	€ 54.36M
Net Income From Continuing And Discontinued Operation	-	€ -2.95M	€ -5.97M	€ -3.63M	€ -5.15M	€ -2.79M
Normalized Income	-	€ -3.75M	€ -5.03M	€ -2.88M	€ -4.18M	€ -2.80M
Interest Expense	-	€ 663.00K	€ 425.00K	€ 438.00K	€ 435.00K	€ 117.00K
EBIT	-	€ -6.47M	€ -6.57M	€ -2.96M	€ -5.50M	€ -1.62M
EBITDA	-	€ -5.77M	€ -5.53M	€ -2.42M	€ -4.67M	€ -931.00K

Currency in EUR

Bioera SpA Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing